MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$33,658K
Net Income
-$62,383K
Net Profit Margin
-185.34%
EPS
-$0.63
Unit: Thousand (K) dollars
Revenue Breakdown
Product
Revenue Under Supply Agreements
Revenue Under Collaboration Agre...
Revenue Breakdown
US
Non Us
JP
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
33,658
22,681
28,087
32,501
Cost of goods sold (including related party amounts of 1,851, 866, 3,084, and 1,354, respectively)
12,846
6,286
6,154
8,191
Research and development (including related party amounts of 612, 582, 1,279, and 1,245, respectively)
4,698
4,336
3,443
2,751
Selling, general and administrative (including related party amounts of 125, 107, 261, and 231, respectively)
77,579
72,204
59,955
74,751
Total operating expenses
95,123
82,826
69,552
85,693
Loss from operations
-61,465
-60,145
-41,465
-53,192
Interest income
1,605
1,968
711*
-
Interest expense (including related party amounts of 124, 0, 246, and 0, respectively)
2,479
2,441
650*
-
Total other (expense) income, net
-874
-473
61
2,041
(loss) income before income tax (benefit) expense
-
-
-41,344*
-
Income tax (benefit) expense
-
-
-20*
-
Net loss
-62,339
-60,618
-41,324
-51,151
Unrealized gaines on available-for-sale securities
-44
-221
132
39
Comprehensive loss
-62,383
-60,839
-41,192
-51,112
Basic EPS
-0.63
-0.61
-0.416
-0.52
Diluted EPS
-0.63
-0.61
-0.416
-0.52
Basic Average Shares
99,312,526
99,296,408
99,035,917
98,807,600
Diluted Average Shares
99,312,526
99,296,408
99,035,917
98,807,600
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
SPRY Income Statement Sankey Diagram
Sankey diagram visualizing SPRY income statement for the period
Comprehensive loss
-$62,383K
(-38.63%↓ Y/Y)
Net loss
-$62,339K
(-38.89%↓ Y/Y)
Unrealized gaines on
available-for-sale securities
-$44K
(62.71%↑ Y/Y)
Product
$26,210K
(104.77%↑ Y/Y)
Revenue Under Supply
Agreements
$7,391K
(2188.24%↑ Y/Y)
Revenue Under
Collaboration Agreements
$57K
(-97.80%↓ Y/Y)
Loss from operations
-$61,465K
(-29.09%↓ Y/Y)
Total other (expense)
income, net
-$874K
(-132.00%↓ Y/Y)
Total revenue
$33,658K
(114.15%↑ Y/Y)
Interest income
$1,605K
Total operating
expenses
$95,123K
(50.20%↑ Y/Y)
Interest expense
(including related party...
$2,479K
Selling, general and
administrative (including...
$77,579K
(42.84%↑ Y/Y)
Cost of goods sold
(including related party...
$12,846K
(157.74%↑ Y/Y)
Research and development
(including related party...
$4,698K
(16.43%↑ Y/Y)
Buy us a coffee
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)